Lomb Eyetelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fourth-Quarter 2023 Financial Results Revenue of $1.173 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $54 Million Adjusted EBITDA 1 of $231 Million Revenue Grew 18%.

New jerseyUnited statesBrent saundersLomb eyetelligenceAudit committeePharmaceuticals segmentLomb corporationRevenue serviceCanada revenue agencyExchange commissionLomb corporation to adjusted net incomeQuarter companyLomb corporation toDrug administrationInternational pharmaceuticalsBausch health companies inc